Reference priceEUR €18.61Original source price: INR 1,692.19. Converted estimates are available by currency selection.
| Brand | Zydus Lifesciences Limited |
|---|---|
| Manufacturer | Zydus Lifesciences Limited |
| Prescription required | Yes |
Elromo 50mg Tablet
Eltrombopag (50mg)
Description
Elromo 50mg Tablet is an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It treats low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP refers to an autoimmune disorder in which the immune system destroys platelets. Platelets are blood cells that aid in clotting and protect blood vessel walls. When platelet levels are low, it can result in severe bleeding and bruising. This tablet is also used in adults to treat low blood counts caused by severe aplastic anaemia (a serious blood disease that occurs when the bone marrow fails to produce enough new blood cells).Benefits
Elromo 50mg Tablet is used to treat, Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection. Severe aplastic anemiaHow to Use
Take this medicine in the dose and duration as advised by your doctor.Specification
Take this medicine in the dose and duration as advised by your doctor.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Eltromo Nausea Diarrhea Upper respiratory tract infection Vomiting Increased liver enzymes Muscle pain Urinary tract infectionDiese Angaben dienen nur als Referenz. Lassen Sie sich vor der Anwendung eines Medikaments von medizinischem Fachpersonal beraten.